← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 15, 2018Last known activity
Apr 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06618885CollaboratorPhase 1Apr 1, 2025
- NCT06618885OfficialPhase 1Apr 1, 2025
- NCT06652737CollaboratorPhase 1Jan 31, 2025
- NCT04695197CollaboratorPhase 3Jan 8, 2021
- NCT04695197Overall official - principal investigatorPhase 3Jan 8, 2021
- NCT03614533CollaboratorPhase 2Oct 15, 2018
Details
- Last known activity
- Apr 1, 2025